News

Although the United States and Canada reached an agreement to scrap Ottawa’s controversial Digital Services Tax – estimated ...
President Donald Trump’s "One Big Beautiful Bill" cuts federal spending on Medicaid and Affordable Care Act marketplaces by about $1 trillion over a decade, according to the nonpartisan Congressional ...
NDTV Profit tracks what analysts are saying about various stocks and sectors. Here are the analyst calls to keep an eye out for on Friday.
Session ID: 2025-07-03:ad726bd3ec659918fedc097e Player Element ID: vjs_video_3 ...
Airsupra (albuterol and budesonide) is a brand-name inhaler that doctors may prescribe to treat asthma in adults. It does not have a generic version. Medicare Part D prescription drug plans may ...
India's largest drugmaker Sun Pharmaceutical Industries Ltd and its peers Cipla Ltd., Glenmark Pharmaceuticals Ltd, Cadila Healthcare Ltd and Biocon Ltd are making cancer drugs under one of the ...
OptumRx said in a statement last April that a review of Cole's claims showed that on the day he visited the pharmacy, he did buy a different asthma medication, generic Albuterol, for a $5 co-pay ...
Cole Schmidtknecht, 22, couldn't pay for his daily inhaler due to the “prohibitively expensive” price increase, but then he died of an asthma attack, per a lawsuit filed by his parents legacy ...
A Wisconsin couple is suing Walgreens and a pharmacy benefits company alleging their son died because he couldn't afford a sudden $500 jump in the cost of his asthma medication ...
Moat Rating: None Fair Value Estimate: $14.50 Price/Fair Value Estimate (as of Feb. 3, 2025): 0.78 Viatris is the second-largest generic manufacturer in our coverage in terms of revenue.
A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a lawsuit filed by his family. Cole Schmidtknecht, 22, suffered from asthma, a ...
A Wisconsin couple is suing Walgreens and a pharmacy benefits management company, alleging that their son died because he couldn't afford a sudden $500 spike in his asthma medication.